ACTU insider trading
Actuate Therapeutics, Inc.
In the past 49 days, 1 insider bought $50K of Actuate Therapeutics, Inc. stock in 1 open-market purchase. The largest purchase was $50K by Daniel M Schmitt (President, CEO and Director) on Oct 28, 2026.
Insider purchases
| Insider | Value | Holdings | Signal | Traded / filed |
|---|---|---|---|---|
Daniel M Schmitt President, CEO and Director |
$50K 140,844 sh @ $0.36 |
+46.7% | Medium
|
Oct 28, 2026 Filed Oct 29, 2026 |
Insider sales
No open-market sales by insiders in this period.
The week's top insider buys, every Monday
Clusters, CEO purchases and the largest buys from the past week's SEC filings. One free email a week.
Unsubscribe any time. No spam, no stock picks.